Targeting ELF in therapy of liver cancer.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001557:Benzenesulfonates / Q000627:therapeutic use*; D002352:Carrier Proteins / Q000037:antagonists & inhibitors* / Q000235:genetics; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy*; D008840:Microfilament Proteins / Q000037:antagonists & inhibitors* / Q000235:genetics; D009536:Niacinamide / Q000031:analogs & derivatives; D010671:Phenylurea Compounds; D011725:Pyridines / Q000627:therapeutic use*; D000077157:Sorafenib; D013049:Spectrin
D000970:Antineoplastic Agents; D001557:Benzenesulfonates; D002352:Carrier Proteins; D008840:Microfilament Proteins; D009536:Niacinamide; D010671:Phenylurea Compounds; D011725:Pyridines; D000077157:Sorafenib; D013049:Spectrin